Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Qsam Biosciences Inc (OP: QSAM )

6.700 -0.300 (-4.29%)
Streaming Delayed Price Updated: 10:16 AM EST, Dec 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Qsam Biosciences Inc

< Previous 1 2 Next >
QSAM Biosciences Adds Rutgers Cancer Institute of New Jersey as Clinical Trial Site To Expand and Advance Study of CycloSam® in the Treatment of Bone Cancer
From QSAM Biosciences Inc.
Via GlobeNewswire
Researchers Develop Wireless Implant to Kill Cancer Cells in Brain Tumors
Via Investor Brand Network
Cancer Studies Provide Researchers with New Information on Ovarian Cancer Development, Growth
Via Investor Brand Network
New Report Praises Advances in Cancer Treatment for Preventing Millions of Deaths
Via Investor Brand Network
QSAM Biosciences Inc. (QSAM) Is ‘One to Watch’
Via Investor Brand Network
Study Finds Antibiotics May Boost Melanoma Growth by Depleting Gut Microbiome
Via Investor Brand Network
TinyGemsBreaks – QSAM Biosciences Inc. (QSAM) Working to Make a Difference in Underserved Patient Populations
Via Investor Brand Network
Exposures Product Safety
Better Screening, Treatment Advances Have Reduced Cancer Fatalities
Via Investor Brand Network
QSAM Biosciences Inc. (QSAM) Working to Halt, Regress Bone Tumors in Children Through Therapeutic Radiopharmaceuticals
Via Investor Brand Network
Scientists Discover Unexpected Way in Which Air Pollution Causes Cancer
Via Investor Brand Network
Researchers Find Cases of Osteosarcoma More Prevalent in Blacks
Via Investor Brand Network
Research Suggests Some 50% of Cancers Result from Preventable Factors
Via Investor Brand Network
Topics Death
Exposures Death
BioMedNewsBreaks – QSAM Biosciences Inc. (QSAM) Receives ‘Marketable Advantage’ Toward Manufacturing, Supply Chain of CycloSam(R)
Via Investor Brand Network
Topics Economy Intellectual Property
Exposures Intellectual Property Product Safety Supply Chain
Study Finds Patients with Hodgkin’s Lymphoma Have Higher Risk of Developing Mental Illnesses
Via Investor Brand Network
New Study Plans to Eliminate Side Effects of Cancer Therapies in Children
Via Investor Brand Network
BioMedNewsBreaks – QSAM Biosciences Inc. (OTCQB: QSAM) Releases Q2 2022 Financial Report, Corporate Update
Via Investor Brand Network
Topics Economy Intellectual Property
Exposures Intellectual Property Product Safety Supply Chain
QSAM Biosciences Inc. (QSAM) Awarded Patent for Potential Breakthrough Bone Cancer Treatment
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Research Shows Access to Health Insurance Invaluable in Early Cancer Diagnosis
Via Investor Brand Network
Study Discovers Common Mechanism Behind Cancer Metastasis, Cardiovascular Disease
Via Investor Brand Network
BioMedNewsBreaks – QSAM Biosciences Inc. (QSAM) Targeting Significant Unmet Medical Need with CycloSam(R)
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks – Why QSAM Biosciences Inc. (QSAM) Is ‘One to Watch’
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Researchers Have Found a New, Fatal Pediatric Subtype of Cancer
Via Investor Brand Network
Scientists Identify Gene Behind Pediatric Bone Cancer
Via Investor Brand Network
BioMedNewsBreaks – QSAM Biosciences Inc. (QSAM) Expands IP Estate with Receipt of Third US Patent for CycloSam(R)
Via Investor Brand Network
Topics Economy Intellectual Property
Exposures Intellectual Property Product Safety Supply Chain
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.